ArticleExperimental physiology2025
Association between thyroid function and acute mountain sickness upon rapid ascent to 3650 m in euthyroid lowlanders in China.
Article in Experimental physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biomarkers and potential subtypes of acute mountain sickness: A state-of-the-science review.Redox biology · 2026Review
- Association between thyroid function and acute mountain sickness upon rapid ascent to 3650 m in euthyroid lowlanders in China.Experimental physiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute mountain sickness (AMS) is a major health issue for lowlanders when they ascend rapidly to altitudes above 2500 m. Thyroid hormones are essential for adaptive responses to the hypoxic environment of high altitude. However, there is limited evidence regarding the association between thyroid function and the prevalence of AMS. This study included 70 healthy euthyroid Chinese lowlanders who ascended from Beijing (44 m above sea level) to Lhasa (3650 m above sea level) by aircraft (flight time, approximately 5 h). The dataset was divided into a training set (80%) and a validation set (20%) for the development and validation of a prediction model. Thyroid hormones, demographic data and blood biochemical data were measured in the week before the ascent. The subjects in the training set were divided into an AMS group and a non-AMS group based on the 2018 Lake Louise Acute Mountain Sickness Scale score. Thyroid hormones and thyroid hormone sensitivity indices were compared between the groups. Multivariable logistic regression analysis revealed that a higher baseline total triiodothyronine (TT3) level (odds ratio (OR) 2.474, 95% confidence interval (CI) 1.083-5.653) and a higher free triiodothyronine/free thyroxine (FT3/FT4) ratio (OR 3.427; 95% CI 1.266-9.280) were independent risk factors for development of AMS. The receiver-operating characteristic and calibration curves showed that the model had good predictive ability and consistency in both the training and validation sets. In China, euthyroid lowlanders with a higher TT3 level or FT3/FT4 ratio are more susceptible to AMS after exposure to high altitudes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.